BioCentury | Jul 17, 2019
Company News

On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas

...promote hair cell regeneration. In 2017, Astellas exercised an option to license worldwide rights from Auration Biotech Inc....
...growth factor (HBEGF; DTR). Allison Johnson, Senior Writer FX-322 Astellas Pharma Inc. Frequency Therapeutics Inc. Heparin-binding EGF-like growth factor (HBEGF) (DTR) AU-935 Auration Biotech Inc....
Items per page:
1 - 1 of 1
BioCentury | Jul 17, 2019
Company News

On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas

...promote hair cell regeneration. In 2017, Astellas exercised an option to license worldwide rights from Auration Biotech Inc....
...growth factor (HBEGF; DTR). Allison Johnson, Senior Writer FX-322 Astellas Pharma Inc. Frequency Therapeutics Inc. Heparin-binding EGF-like growth factor (HBEGF) (DTR) AU-935 Auration Biotech Inc....
Items per page:
1 - 1 of 1